Literature DB >> 28137237

Model Systems for Pulmonary Infectious Diseases: Paradigms of Anthrax and Tuberculosis.

Gunjan Arora1, Richa Misra2, Andaleeb Sajid3.   

Abstract

Robert Koch utilized animal model systems to put forward his postulates while discovering the etiological agents of anthrax and tuberculosis, Bacillus anthracis and Mycobacterium tuberculosis, respectively. After more than 130 years, we have achieved limited success towards understanding these two pestilences, which have propagated as scourge against humans. B. anthracis and M. tuberculosis are diverse organisms, which share a common evolutionary path in tropics. They adapt unique strategies to overcome unfavorable conditions and surpass the host defense mechanisms. B. anthracis is an endospore forming bacteria that primarily acts by releasing toxins in the host cells.. M. tuberculosis is an intracellular bacteria that resides within the host macrophages by blocking phagosome-lysosome fusion events and ensuring its own survival. The bacterium can remain dormant for long periods, and when activated, it spreads in lungs and other extrapulmonary sites leading to formation of necrotic granulomas. The two diseases are immunologically distinct examples of inducing primarily either humoral or cell mediated immunity. Natural immune response to the two diseases probably explains early success achieved with the anthrax vaccine, while the hunt for successful tuberculosis prevention is still on. For comprehensive understanding of these diseases, model systems are of utmost importance that can alleviate detailed assessment of disease etiology and introductory treatment regimes. In this review, we discuss the various in vitro and in vivo model systems used to study these two diseases, discussing their contributions and recent themes. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Bacillus anthracis; Cell lines; Guinea pig; Human subjects; Mice; Mycobacterium tuberculosis; Non-human primates; Rabbit; Zebrafish

Mesh:

Year:  2017        PMID: 28137237     DOI: 10.2174/1568026617666170130111324

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  13 in total

1.  Computational tools for modern vaccine development.

Authors:  Andaleeb Sajid; Yogendra Singh; Pratyoosh Shukla
Journal:  Hum Vaccin Immunother       Date:  2019-12-18       Impact factor: 3.452

2.  The Ser/Thr protein kinase PrkC imprints phenotypic memory in Bacillus anthracis spores by phosphorylating the glycolytic enzyme enolase.

Authors:  Richa Virmani; Andaleeb Sajid; Anshika Singhal; Mohita Gaur; Jayadev Joshi; Ankur Bothra; Richa Garg; Richa Misra; Vijay Pal Singh; Virginie Molle; Ajay K Goel; Archana Singh; Vipin C Kalia; Jung-Kul Lee; Yasha Hasija; Gunjan Arora; Yogendra Singh
Journal:  J Biol Chem       Date:  2019-04-05       Impact factor: 5.157

3.  5G, Big Data, and AI for Smart City and Prevention of Virus Infection.

Authors:  Shumin Ren; Bairong Shen
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 4.  Multi-functionalized nanocarriers targeting bacterial reservoirs to overcome challenges of multi drug-resistance.

Authors:  Maria Hassan Kiani; Muhammad Imran; Abida Raza; Gul Shahnaz
Journal:  Daru       Date:  2020-03-19       Impact factor: 3.117

Review 5.  Current Status and Trends in Prophylaxis and Management of Anthrax Disease.

Authors:  Vladimir Savransky; Boris Ionin; Joshua Reece
Journal:  Pathogens       Date:  2020-05-12

Review 6.  The Immune Escape Mechanisms of Mycobacterium Tuberculosis.

Authors:  Weijie Zhai; Fengjuan Wu; Yiyuan Zhang; Yurong Fu; Zhijun Liu
Journal:  Int J Mol Sci       Date:  2019-01-15       Impact factor: 6.208

7.  The blood transcriptional signature for active and latent tuberculosis.

Authors:  Min Deng; Xiao-Dong Lv; Zhi-Xian Fang; Xin-Sheng Xie; Wen-Yu Chen
Journal:  Infect Drug Resist       Date:  2019-01-30       Impact factor: 4.003

8.  Forecasting the seasonality and trend of pulmonary tuberculosis in Jiangsu Province of China using advanced statistical time-series analyses.

Authors:  Qiao Liu; Zhongqi Li; Ye Ji; Leonardo Martinez; Ui Haq Zia; Arshad Javaid; Wei Lu; Jianming Wang
Journal:  Infect Drug Resist       Date:  2019-07-26       Impact factor: 4.003

9.  Infection and RNA-seq analysis of a zebrafish tlr2 mutant shows a broad function of this toll-like receptor in transcriptional and metabolic control and defense to Mycobacterium marinum infection.

Authors:  Wanbin Hu; Shuxin Yang; Yasuhito Shimada; Magnus Münch; Rubén Marín-Juez; Annemarie H Meijer; Herman P Spaink
Journal:  BMC Genomics       Date:  2019-11-20       Impact factor: 3.969

Review 10.  Tuberculosis IRIS: Pathogenesis, Presentation, and Management across the Spectrum of Disease.

Authors:  Carson M Quinn; Victoria Poplin; John Kasibante; Kyle Yuquimpo; Jane Gakuru; Fiona V Cresswell; Nathan C Bahr
Journal:  Life (Basel)       Date:  2020-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.